AMBROSE KRISTEN (SVP & Chief Accounting Officer) sold 3.1% of their position (223.00 shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $108.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/26/2026ACC: 0000875320-26-000104
Officer· SVP & Chief Accounting Officer
Since May 2021
-769.00
Net shares
Net seller
$373.3K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
769.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−546.00
Price / share
$485.11
Trade value
$264.87K
% of position
7.0%
2/24/2026
7.75K→7.20K
Common Stock
Direct
Shares
−223.00
Price / share
$486.35
Trade value
$108.46K
% of position
3.1%
2/25/2026
7.20K→6.98K
Total
Net shares
−769.00
Net value
-$373.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2026 | F · Tax Withholding | −546.00 | $485.11 | $264.87K | 7.0% | 7.75K | 7.20K |
| Common Stock Direct | 2/25/2026 | S · Sale | −223.00 | $486.35 | $108.46K | 3.1% | 7.20K | 6.98K |
| Total | −769.00 | -$373.33K | ||||||
Derivative Transactions0
No derivative transactions reported